BIOTECHNOLOGIESUK LIMITED

Company number 12923403 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

BIOTECHNOLOGIESUK LIMITED - Analysis Report

Company Number: 12923403

Analysis Date: 2025-07-19 12:24 UTC

  1. Risk Rating: HIGH
    The company shows a significant deterioration in financial position as of the latest financial year (2024), with net current liabilities and net negative assets. This indicates potential solvency issues and inability to meet short-term obligations.

  2. Key Concerns:

  • Negative net current assets of £25,903 and net liabilities of £24,771 as at 31/10/2024, reversing prior positive net assets of £121,137.
  • Current liabilities remain consistent (~£30,000) but current assets have dropped sharply from £148,682 to £4,923, signaling liquidity constraints.
  • No employees reported and minimal share capital (£1), which may indicate limited operational capacity or undercapitalization.
  1. Positive Indicators:
  • The company is up to date with statutory filings and not overdue on accounts or confirmation statements, reflecting regulatory compliance.
  • The sole director and significant control holder, Stela Stefanova, has maintained continuous appointment since incorporation, suggesting stable management continuity.
  • The company qualifies as a micro-entity and benefits from simplified reporting, reducing compliance burden.
  1. Due Diligence Notes:
  • Investigate reasons behind the sharp decline in current assets and resultant negative working capital in 2024.
  • Review cash flow statements and creditor arrangements to assess whether the company can meet its debts as they fall due.
  • Understand the nature of operations given no employees and minimal share capital; clarify revenue streams and business viability.
  • Confirm whether the company has access to additional financing or capital injections from the controlling shareholder or other sources.
  • Ascertain any contingent liabilities or off-balance sheet exposures that may exacerbate financial risks.

Perspective: Investment Risk Assessor · Model: gpt-4.1-mini · Generated 19 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.